Evaluation of short and mid-term clinical outcomes in patients with aortic coarctation treated with self-expandable stents.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 05 2024
Historique:
received: 05 02 2024
accepted: 20 05 2024
medline: 24 5 2024
pubmed: 24 5 2024
entrez: 23 5 2024
Statut: epublish

Résumé

The present study aimed to evaluate the outcomes of percutaneous treatment of aortic coarctation using self-expandable uncovered Nitinol stents. We conducted a retrospective clinical data review of all patients with aortic coarctation and treated with self-expandable uncovered Nitinol stents at our institution between 2009 and 2019. The gradient pressure across the coarctation site was measured using aortography. Follow-up echocardiography and computed tomography angiography were performed to assess possible stent complications. A total of 127 stents were successfully implanted in 125 patients (64.8% males) with a mean age of 35.36 ± 11.9 years. The gradient across the coarctation site decreased significantly from 67.48 ± 14.79 to 5.04 ± 3.01 mmHg (P < 0.001) after self-expandable stent implantation. Systolic blood pressure (SBP) decreased significantly from 175.53 ± 15.99 to 147.22 ± 12.83 mmHg (P < 0.001) after self-expandable stenting. There were no major technical or clinical complications, including balloon rupture, aneurysmal formation, infection, secondary stent migration, thrombosis, death during the procedure, and in-hospital mortality. On a mean follow-up of 48 ± 23.6 months (12-120 months), the gradient [from 59.43 ± 15.42 to 3.72 ± 1.38 mmHg (P < 0.001)] and SBP [from 175.53 ± 15.99 to 127.99 ± 7.82 mmHg (P < 0.001)] decreased significantly. There was no mortality, aneurysmal formation in the stent site, dislocation, or aortic re-stenosis requiring intervention during mid-term follow-up. Treatment of aortic coarctation using a self-expandable uncovered nitinol stent is safe and effective with promising mid-term outcomes.

Identifiants

pubmed: 38783056
doi: 10.1038/s41598-024-62607-w
pii: 10.1038/s41598-024-62607-w
doi:

Substances chimiques

nitinol 2EWL73IJ7F
Alloys 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11748

Informations de copyright

© 2024. The Author(s).

Références

Ganigara, M. et al. Preoperative physiology, imaging, and management of coarctation of aorta in children. Semin. Cardiothorac. Vasc. Anesth. 23, 379–386. https://doi.org/10.1177/1089253219873004 (2019).
doi: 10.1177/1089253219873004 pubmed: 31535945
Chetan, D. & Mertens, L. L. Challenges in diagnosis and management of coarctation of the aorta. Curr. Opin. Cardiol. 37, 115–122. https://doi.org/10.1097/hco.0000000000000934 (2022).
doi: 10.1097/hco.0000000000000934 pubmed: 34857719
Fox, E. B., Latham, G. J., Ross, F. J. & Joffe, D. Perioperative and anesthetic management of coarctation of the aorta. Semin. Cardiothorac. Vasc. Anesth. 23, 212–224. https://doi.org/10.1177/1089253218821953 (2019).
doi: 10.1177/1089253218821953 pubmed: 30614372
Gholoobi, A. et al. Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: A randomised, double-blind, placebo-controlled clinical trial. Inflammopharmacology 29, 1379–1387. https://doi.org/10.1007/s10787-021-00865-0 (2021).
doi: 10.1007/s10787-021-00865-0 pubmed: 34420187
Ebrahimi, M. et al. Evaluation of long-term outcomes of percutaneous coronary intervention in patients with moderate to severe calcified coronary artery lesions. Health Sci. Rep. 6, e1588. https://doi.org/10.1002/hsr2.1588 (2023).
doi: 10.1002/hsr2.1588 pubmed: 37779669 pmcid: 10539625
Kim, Y. Y., Andrade, L. & Cook, S. C. Aortic coarctation. Cardiol. Clin. 38, 337–351. https://doi.org/10.1016/j.ccl.2020.04.003 (2020).
doi: 10.1016/j.ccl.2020.04.003 pubmed: 32622489
Arya, B. & Maskatia, S. A. Coarctation of the aorta: Prenatal assessment, postnatal management and neonatal outcomes. Semin. Perinatol. 46, 151584. https://doi.org/10.1016/j.semperi.2022.151584 (2022).
doi: 10.1016/j.semperi.2022.151584 pubmed: 35422354
Sistani, S. et al. The discovery of major heart risk factors among young patients with ischemic heart disease using k-means techniques. Int. Cardiovasc. Res. J. 13, 3 (2019).
Dastani, M. et al. Three months of combination therapy with nano-curcumin reduces the inflammation and lipoprotein (a) in type 2 diabetic patients with mild to moderate coronary artery disease: Evidence of a randomized, double-blinded, placebo-controlled clinical trial. Biofactors 49, 108–118. https://doi.org/10.1002/biof.1874 (2023).
doi: 10.1002/biof.1874 pubmed: 35674733
Luijendijk, P. et al. Surgical versus percutaneous treatment of aortic coarctation: New standards in an era of transcatheter repair. Expert Rev. Cardiovasc. Ther. 10, 1517–1531. https://doi.org/10.1586/erc.12.158 (2012).
doi: 10.1586/erc.12.158 pubmed: 23253276
Egan, M. & Holzer, R. J. Comparing balloon angioplasty, stenting and surgery in the treatment of aortic coarctation. Expert Rev. Cardiovasc. Ther. 7, 1401–1412. https://doi.org/10.1586/erc.09.111 (2009).
doi: 10.1586/erc.09.111 pubmed: 19900023
Forbes, T. J. et al. Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: An observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J. Am. Coll. Cardiol. 58, 2664–2674. https://doi.org/10.1016/j.jacc.2011.08.053 (2011).
doi: 10.1016/j.jacc.2011.08.053 pubmed: 22152954
Harris, K. C., Du, W., Cowley, C. G., Forbes, T. J. & Kim, D. W. A prospective observational multicenter study of balloon angioplasty for the treatment of native and recurrent coarctation of the aorta. Catheteriz. Cardiovasc. Interv. 83, 1116–1123. https://doi.org/10.1002/ccd.25284 (2014).
doi: 10.1002/ccd.25284
Sadeghipour, P. et al. Balloon-expandable cheatham-platinum stents versus self-expandable nitinol stents in coarctation of aorta: A randomized controlled trial. JACC Cardiovasc. Interv. 15, 308–317. https://doi.org/10.1016/j.jcin.2021.11.025 (2022).
doi: 10.1016/j.jcin.2021.11.025 pubmed: 35144787
Haji Zeinali, A. M., Sadeghian, M., Qureshi, S. A. & Ghazi, P. Midterm to long-term safety and efficacy of self-expandable nitinol stent implantation for coarctation of aorta in adults. Catheter. Cardiovasc. Interv. 90, 425–431. https://doi.org/10.1002/ccd.27178 (2017).
doi: 10.1002/ccd.27178 pubmed: 28707350
Haji-Zeinali, A. M., Ghazi, P. & Alidoosti, M. Self-expanding nitinol stent implantation for treatment of aortic coarctation. J. Endovasc. Ther. 16, 224–232. https://doi.org/10.1583/08-2589.1 (2009).
doi: 10.1583/08-2589.1 pubmed: 19456194
de Wolf, M. A. et al. Short-term clinical experience with a dedicated venous nitinol stent: Initial results with the sinus-venous stent. Eur. J. Vasc. Endovasc. Surg. 50, 518–526. https://doi.org/10.1016/j.ejvs.2015.05.011 (2015).
doi: 10.1016/j.ejvs.2015.05.011 pubmed: 26187656
van Vuuren, T. M., de Wolf, M. A. & Wittens, C. H. Relevance of flexibility versus radial force in rigid versus more flexible venous stents? Phlebology 34, 459–465. https://doi.org/10.1177/0268355518819398 (2019).
doi: 10.1177/0268355518819398 pubmed: 30582738
Alkashkari, W., Albugami, S. & Hijazi, Z. M. Management of coarctation of the aorta in adult patients: State of the art. Korean Circ. J. 49, 298–313. https://doi.org/10.4070/kcj.2018.0433 (2019).
doi: 10.4070/kcj.2018.0433 pubmed: 30895757 pmcid: 6428953
Stines, J. R. & Holzer, R. J. Stenting of aortic coarctation: Technical considerations and procedural outcomes. Prog. Pediatr. Cardiol. 33, 161–167. https://doi.org/10.1016/j.ppedcard.2012.02.009 (2012).
doi: 10.1016/j.ppedcard.2012.02.009
Forbes, T. J. & Gowda, S. T. Intravascular stent therapy for coarctation of the aorta. Method. DeBakey Cardiovasc. J. 10, 82–87. https://doi.org/10.14797/mdcj-10-2-82 (2014).
doi: 10.14797/mdcj-10-2-82
Kische, S. et al. Percutaneous treatment of adult isthmic aortic coarctation. Circ. Cardiovasc. Interv. 8, e001799. https://doi.org/10.1161/CIRCINTERVENTIONS.114.001799 (2015).
doi: 10.1161/CIRCINTERVENTIONS.114.001799 pubmed: 25582143
Firoozi, A. et al. Self-expanding versus balloon-expandable stents in patients with isthmic coarctation of the aorta. Am. J. Cardiol. 122, 1062–1067 (2018).
doi: 10.1016/j.amjcard.2018.06.005 pubmed: 30139526
Langroodi, H. M. et al. Endovascular stents for coarctation of aorta in children and adolescents: Early and intermediate-term results. Tehran Univ. Med. J. 68, 341–347 (2010).
Kasar, T. et al. Balloon-expandable stents for native coarctation of the aorta in children and adolescents. Medicine 101, e32332. https://doi.org/10.1097/md.0000000000032332 (2022).
doi: 10.1097/md.0000000000032332 pubmed: 36595787 pmcid: 9794334
Sadeghipour, P. et al. Balloon-expandable cheatham-platinum stents versus self-expandable nitinol stents in coarctation of aorta: A randomized controlled trial. Cardiovasc. Interv. 15, 308–317 (2022).
Kenny, D. et al. Self-expanding and balloon expandable covered stents in the treatment of aortic coarctation with or without aneurysm formation. Catheteriz. Cardiovasc. Interv. 72, 65–71. https://doi.org/10.1002/ccd.21559 (2008).
doi: 10.1002/ccd.21559
Tyagi, S., Singh, S., Mukhopadhyay, S. & Kaul, U. A. Self- and balloon-expandable stent implantation for severe native coarctation of aorta in adults. Am. Heart J. 146, 920–928. https://doi.org/10.1016/S0002-8703(03)00434-4 (2003).
doi: 10.1016/S0002-8703(03)00434-4 pubmed: 14597945
Haddad, R. N. et al. Multicentre experience with optimus balloon-expandable cobalt-chromium stents in congenital heart disease interventions. Open Heart 10, 2157. https://doi.org/10.1136/openhrt-2022-002157 (2023).
doi: 10.1136/openhrt-2022-002157
Hatoum, I., Haddad, R. N., Saliba, Z. & Abdel Massih, T. Endovascular stent implantation for aortic coarctation: Parameters affecting clinical outcomes. Am. J. Cardiovasc. Dis. 10, 528–537 (2020).
pubmed: 33489455 pmcid: 7811920
Cheng, W. et al. Stent implantation and balloon angioplasty for native and recurrent coarctation of the aorta. Int. Heart J. 64, 10–21. https://doi.org/10.1536/ihj.21-643 (2023).
doi: 10.1536/ihj.21-643 pubmed: 36682763
Saadi, R. P., Saadi, E. K., Tagliari, A. P. & Saadi, M. P. Endovascular treatment of coarctation of the aorta with a self-expanding endoprosthesis: How I do it using the braile dominus(®) coarctation aorta device. Braz. J. Cardiovasc. Surg. 36, 817–821. https://doi.org/10.21470/1678-9741-2020-0345 (2021).
doi: 10.21470/1678-9741-2020-0345 pubmed: 34236790 pmcid: 8641778

Auteurs

Mahmoud Mohammadzadeh Shabestari (M)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Ali Eshraghi (A)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Farnaz Hakim Attar (F)

Islamic Azad University, Central Tehran Branch, Tehran, Iran.

Fereshteh Ghaderi (F)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Hoorak Poorzand (H)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Amir Hossein Mohammadzadeh Shabestari (AH)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Behzad Alizadeh (B)

Division of Congenital and Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Negar Morovatdar (N)

Clinical Research Development Unit, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.

Bahram Shahri (B)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Hedieh Alimi (H)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Tayyebi (M)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Arash Gholoobi (A)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Vahid Reza Askari (VR)

Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran.

Yousef Ali Garivani (YA)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Mohammadzadeh Shabestari (M)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. mohammad_701@yahoo.com.

Vafa Baradaran Rahimi (V)

Department of Cardiovascular Diseases, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. vafa_br@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH